Catalan biomedical companies attracted €106 million in investment in 2018 for new drugs and technology

by CataloniaBio

Venture capital funds continue to lead investment, but there is growing interest in the sector from business angels. 60% of Catalan pharmaceutical groups invest in start-ups to fuel open innovation.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream